Incyte Statistics
Total Valuation
Incyte has a market cap or net worth of $18.35 billion. The enterprise value is $15.46 billion.
| Market Cap | 18.35B |
| Enterprise Value | 15.46B |
Important Dates
The last earnings date was Tuesday, October 28, 2025, before market open.
| Earnings Date | Oct 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Incyte has 196.32 million shares outstanding. The number of shares has decreased by -6.58% in one year.
| Current Share Class | 196.32M |
| Shares Outstanding | 196.32M |
| Shares Change (YoY) | -6.58% |
| Shares Change (QoQ) | +1.35% |
| Owned by Insiders (%) | 0.68% |
| Owned by Institutions (%) | 85.79% |
| Float | 162.77M |
Valuation Ratios
The trailing PE ratio is 15.84 and the forward PE ratio is 12.54. Incyte's PEG ratio is 0.06.
| PE Ratio | 15.84 |
| Forward PE | 12.54 |
| PS Ratio | 3.77 |
| Forward PS | 3.48 |
| PB Ratio | 3.94 |
| P/TBV Ratio | 4.19 |
| P/FCF Ratio | 15.33 |
| P/OCF Ratio | 14.67 |
| PEG Ratio | 0.06 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.68, with an EV/FCF ratio of 12.92.
| EV / Earnings | 13.01 |
| EV / Sales | 3.21 |
| EV / EBITDA | 11.68 |
| EV / EBIT | 12.59 |
| EV / FCF | 12.92 |
Financial Position
The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.20 |
| Quick Ratio | 2.86 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.03 |
| Interest Coverage | 542.31 |
Financial Efficiency
Return on equity (ROE) is 30.39% and return on invested capital (ROIC) is 19.44%.
| Return on Equity (ROE) | 30.39% |
| Return on Assets (ROA) | 13.54% |
| Return on Invested Capital (ROIC) | 19.44% |
| Return on Capital Employed (ROCE) | 24.61% |
| Revenue Per Employee | $1.84M |
| Profits Per Employee | $454,178 |
| Employee Count | 2,617 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 27.22 |
Taxes
In the past 12 months, Incyte has paid $399.65 million in taxes.
| Income Tax | 399.65M |
| Effective Tax Rate | 25.16% |
Stock Price Statistics
The stock price has increased by +26.44% in the last 52 weeks. The beta is 0.74, so Incyte's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +26.44% |
| 50-Day Moving Average | 86.31 |
| 200-Day Moving Average | 72.76 |
| Relative Strength Index (RSI) | 66.38 |
| Average Volume (20 Days) | 2,305,139 |
Short Selling Information
The latest short interest is 9.36 million, so 4.77% of the outstanding shares have been sold short.
| Short Interest | 9.36M |
| Short Previous Month | 8.50M |
| Short % of Shares Out | 4.77% |
| Short % of Float | 5.75% |
| Short Ratio (days to cover) | 5.56 |
Income Statement
In the last 12 months, Incyte had revenue of $4.81 billion and earned $1.19 billion in profits. Earnings per share was $5.90.
| Revenue | 4.81B |
| Gross Profit | 2.72B |
| Operating Income | 1.23B |
| Pretax Income | 1.59B |
| Net Income | 1.19B |
| EBITDA | 1.32B |
| EBIT | 1.23B |
| Earnings Per Share (EPS) | $5.90 |
Balance Sheet
The company has $2.93 billion in cash and $41.27 million in debt, giving a net cash position of $2.89 billion or $14.71 per share.
| Cash & Cash Equivalents | 2.93B |
| Total Debt | 41.27M |
| Net Cash | 2.89B |
| Net Cash Per Share | $14.71 |
| Equity (Book Value) | 4.65B |
| Book Value Per Share | 23.71 |
| Working Capital | 2.94B |
Cash Flow
In the last 12 months, operating cash flow was $1.25 billion and capital expenditures -$54.37 million, giving a free cash flow of $1.20 billion.
| Operating Cash Flow | 1.25B |
| Capital Expenditures | -54.37M |
| Free Cash Flow | 1.20B |
| FCF Per Share | $6.10 |
Margins
Gross margin is 56.49%, with operating and profit margins of 25.52% and 24.69%.
| Gross Margin | 56.49% |
| Operating Margin | 25.52% |
| Pretax Margin | 33.00% |
| Profit Margin | 24.69% |
| EBITDA Margin | 27.51% |
| EBIT Margin | 25.52% |
| FCF Margin | 24.87% |
Dividends & Yields
Incyte does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.58% |
| Shareholder Yield | 6.58% |
| Earnings Yield | 6.48% |
| FCF Yield | 6.52% |
Analyst Forecast
The average price target for Incyte is $84.50, which is -9.61% lower than the current price. The consensus rating is "Buy".
| Price Target | $84.50 |
| Price Target Difference | -9.61% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | -0.24% |
| EPS Growth Forecast (5Y) | 96.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 1, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 1, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Incyte has an Altman Z-Score of 6.84 and a Piotroski F-Score of 7.
| Altman Z-Score | 6.84 |
| Piotroski F-Score | 7 |